Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane

First Page		Document Content
Date: 2015-08-29 15:36:41 Ion channels Electrophysiology Biology Integral membrane proteins Physiology Neuroscience Carbamates Retigabine Potassium channel Voltage-gated potassium channel		Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane Add to Reading List Source URL: theplesslab.com Download Document from Source Website File Size: 531,25 KB Share Document on Facebook

	B’SYS GmbH HEK-Tet hERG Cell Line Specification Sheet © B’SYS GmbH DocID: 1rqng - View Document
	B’SYS GmbH CHO KVLQT1/minK Cell Line Specification Sheet © B’SYS GmbH DocID: 1rn53 - View Document
	Atomic basis for binding of a novel epilepsy drug Epilepsy is a highly common neurological disorder, affecting about 1% of the worldwide population. The disease is often caused by mutations in genes encoding for membrane DocID: 1qUxQ - View Document
	© Copyright 2004 by the American Chemical Society Volume 43, Number 5 February 10, 2004 DocID: 1qzS5 - View Document
	Microsoft Word - Blunck_lecture_program.docx DocID: 1qfjf - View Document